The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus.
Eric G RomanowskiKathleen A YatesJohn E RomanowskiRobert M Q ShanksRegis P KowalskiPublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
REM demonstrated anti-adenovirus activity in a range similar to that demonstrated by cidofovir. UMF and IVR demonstrated larger ranges of antiviral activity than CDV and REM across the panel of HAdV types. The anti-adenovirus activity of HCQ could not be determined due to cytotoxicity. Further investigation of REM, UMF, and IVR as antivirals for adenovirus is indicated.
Keyphrases